Global Medical REIT Inc. financial data

Symbol
GMRE, GMRE-PA on NYSE
Location
7373 Wisconsin Avenue, Suite 800, Bethesda, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 137 % +20.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66.9M shares +1.97%
Common Stock, Shares, Outstanding 66.9M shares +1.97%
Entity Public Float 561M USD -0.53%
Common Stock, Value, Issued 67K USD +1.52%
Weighted Average Number of Shares Outstanding, Basic 66.9M shares +1.97%
Weighted Average Number of Shares Outstanding, Diluted 66.9M shares +1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 142M USD +3.03%
General and Administrative Expense 21.7M USD +23.3%
Earnings Per Share, Basic 0 USD/shares +80%
Earnings Per Share, Diluted 0 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.58M USD +32.2%
Operating Lease, Right-of-Use Asset 13.3M USD +79%
Goodwill 5.9M USD 0%
Other Assets, Noncurrent 13.7M USD +94.7%
Assets 1.3B USD +4.49%
Employee-related Liabilities, Current 3.2M USD
Liabilities 772M USD +16.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 10.4M USD -62.4%
Retained Earnings (Accumulated Deficit) -317M USD -17.7%
Stockholders' Equity Attributable to Parent 503M USD -9.57%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 525M USD -9.22%
Liabilities and Equity 1.3B USD +4.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 12.3M USD -14.1%
Net Cash Provided by (Used in) Financing Activities 13.6M USD
Net Cash Provided by (Used in) Investing Activities -27.2M USD -902%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 66.9M shares +1.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD -225%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.23M USD +18%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.57M USD +2.51%
Operating Lease, Liability 13.6M USD +76.5%
Depreciation 41.8M USD +3.1%
Lessee, Operating Lease, Liability, to be Paid 32.4M USD +148%
Property, Plant and Equipment, Gross 1.52B USD +7.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.15M USD +51.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.13M USD +53.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.8M USD +250%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.17M USD +52.1%
Preferred Stock, Shares Issued 3.11M shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.19M USD +50.3%
Operating Lease, Payments 229K USD +45.9%
Additional Paid in Capital 734M USD +1.61%
Preferred Stock, Shares Outstanding 3.11M shares 0%
Interest Expense 29.5M USD +2.83%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%